BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 14691125)

  • 1. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
    Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
    J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in the treatment and molecular biology of non-small cell lung cancer.
    Erlich R; Levitt ML
    Compr Ther; 1995 Aug; 21(8):445-57. PubMed ID: 8536445
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal therapy for unresectable stage III non-small-cell lung cancer.
    Vokes EE
    J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].
    Bompas E; Freyer G; Trillet-Lenoir V
    Bull Cancer; 1998 Feb; 85(2):125-7. PubMed ID: 9752328
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of non-small-cell lung cancer (NSCLC) in elderly patients].
    Westeel V
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S35-4S38. PubMed ID: 15687992
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
    Belani CP
    Clin Lung Cancer; 2003 Jul; 5(1):11-2. PubMed ID: 14596696
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
    Hennequin C; Girard N; Mornex F
    Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].
    Goldobenko GV; Kanaev SV
    Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730
    [No Abstract]   [Full Text] [Related]  

  • 11. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction therapy before surgery for non-small cell lung cancer.
    Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
    Rays; 2004; 29(4):445-52. PubMed ID: 15852734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current drug therapy of bronchial cancer].
    Drings P
    Verh Dtsch Ges Inn Med; 1990; 96():228-41. PubMed ID: 1965460
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
    Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L
    J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
    Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
    J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specificities of resectable Stage III non-small-cell lung cancer].
    Thibout Y; Cortot A; Mornex F
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S5-4S7. PubMed ID: 15687985
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy for lung cancer.
    Ikhlaque N; Baumann MA
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative data from lung cancer trial may change practice guidelines, study designs.
    McNeil C
    J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.